SENTI BIOSCIENCES INC (SNTI) Stock Income Statement
NASDAQ:SNTI - Nasdaq - US81726A2096 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 2.56M | 4.29M | 2.76M | 570.00K | |||
| Operating Expenses | 60.73M | 69.33M | 74.92M | 43.21M | 25.26M | |||
| Research and Development | 34.36M | 32.15M | 34.07M | 21.96M | 15.96M | |||
| Selling, General, and Administrative Expenses | 23.51M | 37.18M | 40.85M | 21.25M | 9.30M | |||
| Operating Income | -60.73M | -66.77M | -70.63M | -40.45M | -24.69M | |||
| Interest Income/Expense | 14.35M | 2.86M | 1.70M | 10.00K | -630.00K | |||
| Other Income/Expense | -6.10M | 6.46M | 9.43M | -14.86M | 5.70M | |||
| Non Recurring Items | -313.00K | -25.96M | 1.29M | -20.00K | -240.00K | |||
| Income Before Taxes | -52.79M | -83.41M | -58.21M | -55.32M | -19.86M | |||
| Net Income | -52.79M | -71.06M | -58.21M | -55.32M | -19.86M | |||
| EBITDA | -54.88M | -61.34M | -69.23M | -39.68M | -24.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -11.49 | -16.01 | -1.32 | -1.27 | -0.45 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -2774.62% | -1356.88% | -2004.35% | -3484.21% | |||
| Operating Profit Margin | N/A | -2606.99% | -1646.39% | -1465.58% | -4331.58% | |||
All data in USD